135 related articles for article (PubMed ID: 32982434)
1. Erratum: Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China [Corrigendum].
Cancer Manag Res; 2020; 12():8409. PubMed ID: 32982434
[TBL] [Abstract][Full Text] [Related]
2. Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China.
Peng W; Zhang F; Wang Z; Li D; He Y; Ning Z; Sheng L; Wang J; Xia X; Yu C; Wang Z; Zhao Y; Liang H; Hu B; Sun C; Wang D; Cheng Y; Pan M; Xia L; Guo X; Zhang Y; Hu Z; Li X; Lu L; Zhang J; Qian H; Xie H; Sun G
Cancer Manag Res; 2020; 12():6977-6985. PubMed ID: 32821164
[TBL] [Abstract][Full Text] [Related]
3. Erratum: The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution [Corrigendum].
Cancer Manag Res; 2020; 12():8079. PubMed ID: 32943939
[TBL] [Abstract][Full Text] [Related]
4. Erratum: Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum].
Cancer Manag Res; 2020; 12():4169-4170. PubMed ID: 32581588
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Palliative Gastrectomy Plus Chemotherapy versus Chemotherapy Alone for Incurable Advanced Gastric Cancer: A Meta-Analysis [Corrigendum].
Cancer Manag Res; 2024; 16():71-72. PubMed ID: 38293291
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of low-dose apatinib in advanced gastric cancer: A real-world study.
Du Y; Cao Q; Jiang C; Liang H; Ning Z; Ji C; Wang J; Zhou C; Jiang Z; Yu C; Li L; Zhao Y; Xu Y; Xu T; Hu W; Wang D; Cheng H; Wang G; Zhou J; Wang S; Zhang Y; Hu Z; Li X; Lu D; Zhang J; Xie H; Sun G
Cancer Med; 2020 Jul; 9(14):5008-5014. PubMed ID: 32441892
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Circular RNA Profiling Reveals That circRNA_104433 Regulates Cell Growth by Targeting miR-497-5p in Gastric Cancer [Corrigendum].
Cancer Manag Res; 2020; 12():9721-9724. PubMed ID: 33116831
[TBL] [Abstract][Full Text] [Related]
8. Erratum: KLF7 Promotes Gastric Carcinogenesis Through Regulation of ANTXR1 [Corrigendum].
Cancer Manag Res; 2021; 13():6113. PubMed ID: 34377029
[TBL] [Abstract][Full Text] [Related]
9. Erratum: CircFLNA Acts as a Sponge of miR-646 to Facilitate the Proliferation, Metastasis, Glycolysis, and Apoptosis Inhibition of Gastric Cancer by Targeting PFKFB2 [Corrigendum].
Cancer Manag Res; 2021; 13():643. PubMed ID: 33531836
[TBL] [Abstract][Full Text] [Related]
10. Erratum: The Development of a Nomogram to Predict Post-Radiation Necrosis in Nasopharyngeal Carcinoma Patients: A Large-Scale Cohort Study [Corrigendum].
Cancer Manag Res; 2020; 12():1371. PubMed ID: 32161491
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Impact of the Time Interval Between Primary Debulking Surgery and Start of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer [Corrigendum].
Cancer Manag Res; 2021; 13():6363-6364. PubMed ID: 34408495
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer [Corrigendum].
Cancer Manag Res; 2020; 12():4957. PubMed ID: 32617018
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Upregulation of Family with Sequence Similarity 83 Member D Expression Enhances Cell Proliferation and Motility via Activation of Wnt/β-Catenin Signaling and Predicts Poor Prognosis in Gastric Cancer [Corrigendum].
Cancer Manag Res; 2021; 13():3381-3383. PubMed ID: 33889026
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Genotype Distribution and Prevalence of Human Papillomavirus Infection in Women in Northern Jiangsu Province of China [Corrigendum].
Cancer Manag Res; 2023; 15():689-690. PubMed ID: 37465081
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment [Corrigendum].
Cancer Manag Res; 2022; 14():1653-1654. PubMed ID: 35547599
[TBL] [Abstract][Full Text] [Related]
16. An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202).
Wang X; Zhang R; Du N; Yang M; Zang A; Liu L; Yu J; Gao J; Zhang J; Fu Z; Ren Y; Ma L; Guo J; Li Q; Li X; Fan Z; Song X; Liu Z; Zhang Y; Li G; Yu Z; Diao J; Jia J; Liang F; Wang H; Sun J; Gao Y; Yang P; Bai C; Ren X; Zhong D
Ther Adv Med Oncol; 2020; 12():1758835920905424. PubMed ID: 32218807
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Prognostic Role of a New Inflammatory Index with Neutrophil-to-Lymphocyte Ratio and Lactate Dehydrogenase (CII: Colon Inflammatory Index) in Patients with Metastatic Colorectal Cancer: Results from the Randomized Italian Trial in Advanced Colorectal Cancer (ITACa) Study [Corrigendum].
Cancer Manag Res; 2020; 12():541. PubMed ID: 32021463
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Safety of Apatinib in Patients with Advanced or Metastatic Adenocarcinoma of Stomach or Gastroesophageal Junction: A Prospective Observation Study.
Shen B; Jiang H; Wang L; Qian J; Shu Y; Chen P; Mao G; Liu B; Zhang X; Liu C; Wu J; Li X; Cai W; Shen W; Wang Q; He J; Hua D; Zhang Z; Zhang Y; Feng J
Onco Targets Ther; 2020; 13():4457-4464. PubMed ID: 32547076
[TBL] [Abstract][Full Text] [Related]
19. Erratum: The Blood Biomarkers of Thyroid Cancer [Corrigendum].
Cancer Manag Res; 2022; 14():49-50. PubMed ID: 35023970
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Traditional Chinese Medicine
Onco Targets Ther; 2022; 15():77-79. PubMed ID: 35087275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
